Delivery Order SPE2DB24D3015-SPE2DB25FFXPR

Award Date 1/3/25
Potential Completion Date 1/6/25
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CIPRO 500 MG TABLET 100S, a pharmaceutical product, and has a ceiling value of $1,243.86. The contract is a Delivery Order with a Firm Fixed Price pricing type, with a period of performance through December 23, 2024. The contract is not designated with a set-aside. Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,514.48 Firm Fixed Price contract is for the delivery of CIPRO 500 MG TABLET 100S, a pharmaceutical product, to support the Department of Defense. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of CIPRO 500 MG TABLET 100S, a common antibiotic medication, to support military healthcare requirements. The firm-fixed-price contract has a ceiling value of $2,538.24 and a period of performance through September 5, 2024. This contract is not designated as a set-aside....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,024.60 firm fixed price delivery order is for the supply of CIPRO 500 MG TABLET 100S. This award is part of Amerisourcebergen Drug Corp's broader indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00, which serves as the primary...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,026.30, is for the delivery of CIPRO 500 MG TABLET 100S, a pharmaceutical product. The contract has no set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,477,006 units of the antibiotic CIPRO 500 mg tablets. The $11,623.76 firm fixed-price Delivery Order has a completion date of November 19, 2024 and does not utilize any set-aside designations. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
The U.S. Defense Logistics Agency (DLA) has awarded a Delivery Order contract valued at $1,321.18 to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is for the supply of CIPRO 500 MG TABLET 100S, a pharmaceutical product, with an ultimate completion date of August 21, 2024. This award is not associated with any set-aside program. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to various federal agencies, including the DLA...
The U.S. Defense Logistics Agency Troop Support Medical has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide CIPRO 500 MG TABLET 100S with a potential value of $1,084.76. The contract has a completion date of February 22, 2024 and was awarded on February 21, 2024. Amerisourcebergen Drug Corp is a prime contractor that holds a large indefinite delivery contract (IDC) with the Defense Logistics Agency for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,830.06 delivery order contract is for CIPRO 500 MG TABLET 100S, with a completion date of December 19, 2024. The contract is classified as Firm Fixed Price. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at up to $2,432.61, is for the delivery of CIPRO 500 MG TABLET 100S, a pharmaceutical product. This is a Firm Fixed Price Delivery Order contract with a completion date of July 26, 2024. Amerisourcebergen, a large pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of...
  • SPE2DB24D3015
    Indefinite Delivery Contract
  • SPE2DB24D3015-SPE2DB25FFXPR
    Delivery Order

This federal contract award, with ID SPE2DB24D3015|SPE2DB25FFXPR, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,664.08, is for the delivery of CIPRO 500 MG TABLET 100S, a pharmaceutical product.

The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of January 6, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

Generated 4/4/25, 9:49 AM